Salesforce Stock Soars 23%: AI Investment Windfall or Real Growth?
💡 Key Takeaway
Salesforce's core business grew a solid 16%, but the stock surge was largely fueled by a $2.7 billion gain from its Anthropic stake, highlighting the growing importance of AI investments.
What Happened: Salesforce's Blockbuster Quarter
Salesforce (CRM) shares skyrocketed nearly 23% on Thursday, marking its second-biggest day ever, after the company reported fiscal Q2 2027 earnings that beat expectations. The headline EPS of $5.90 was up 103% year over year, but a closer look reveals that a significant portion of that profit came from investment gains, not software sales.
The company recorded $2.6 billion in net investment gains, with $2.7 billion of that tied to its stake in AI company Anthropic. This single investment now accounts for about 45% of Salesforce's $11.3 billion strategic investment portfolio, up from 22% in January.
Excluding the investment gain, adjusted EPS was about $3.37, up 16% from $2.91 a year ago. Revenue grew 11% to $11.3 billion, with subscription revenue up 12%. Operating cash flow surged 71% to $1.3 billion.
Salesforce also announced a partnership with Anthropic called 'Claudeforce,' integrating Salesforce data into Anthropic's Claude chatbot. This move positions AI as an opportunity rather than a threat to its business.
The company raised its full-year revenue guidance to $46.1-$46.4 billion, implying 11-12% growth. AI products like Agentforce and Data 360 saw combined ARR surge over 210% to $3.9 billion.
Why It Matters: AI Strategy Takes Center Stage
This quarter highlights a pivotal shift for Salesforce. The investment gain from Anthropic is a double-edged sword: it boosts reported profits but also raises questions about the sustainability of earnings. Investors should focus on the core business growth of 16% adjusted EPS, which is solid for a company of this size.
The partnership with Anthropic is arguably more significant than the investment gain. It signals that Salesforce is embracing AI as a complement to its offerings, not just a threat. The 'Claudeforce' integration could drive adoption of Salesforce's CRM tools among AI users, creating new revenue streams.
The rapid growth of AI products (Agentforce ARR up 240%) shows that Salesforce is successfully monetizing AI. This could be a major competitive advantage against rivals like Microsoft and Oracle, who are also pushing AI solutions.
However, the reliance on investment gains for profit growth is a concern. If Anthropic's valuation drops, it could negatively impact future earnings. Investors should monitor the core business's ability to sustain growth without these one-time boosts.
At 16 times forward earnings, the stock is reasonably priced, but the market's reaction suggests it's pricing in continued AI momentum. The real test will be whether Salesforce can maintain this growth trajectory in the coming quarters.
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight
Salesforce is a buy, but focus on the core business growth and AI partnership rather than the one-time investment gain.
The core business grew 16% adjusted EPS, AI products are accelerating, and the Anthropic partnership mitigates AI disruption fears. The stock is reasonably priced at 16x forward earnings, offering a good risk-reward for long-term investors.
What This Means for Me
